For scientists and procurement specialists engaged in research and development, understanding the properties and potential applications of chemical compounds is fundamental to project success. Methyl 2-Bromomethylbenzoate, identified by CAS number 2417-73-4, is a specialized organic intermediate that plays a significant role in various synthetic pathways, particularly within the pharmaceutical sector. Delving into its characteristics can unlock new possibilities for innovation.

Methyl 2-Bromomethylbenzoate is typically described as an off-white to yellow solid, with a defined melting point ranging from 32-32.5 °C. Its boiling point is noted at 114 °C under a pressure of 0.44 Torr, indicating its volatility under reduced conditions. The compound’s density is approximately 1.460±0.06 g/cm³. In terms of solubility, it exhibits sparing solubility in chloroform and slight solubility in hexane, which are important considerations for reaction solvent selection and purification processes. It is recommended to store this chemical under an inert atmosphere, such as nitrogen or argon, at refrigerated temperatures (2-8 °C) to maintain its integrity.

The chemical structure of Methyl 2-Bromomethylbenzoate features a benzene ring substituted with a methyl ester group and a bromomethyl group at the ortho position. This bromomethyl group is particularly noteworthy for its reactivity. It acts as a good leaving group, making the compound an excellent substrate for nucleophilic substitution reactions. This reactivity is central to its utility as a building block in complex organic synthesis, allowing for the introduction of various functional groups or molecular fragments.

A key application highlighted for Methyl 2-Bromomethylbenzoate is its role as a reactant in the preparation of compounds exhibiting neuroprotective activity. This makes it a highly valuable intermediate for researchers focused on developing treatments for neurological diseases. By reacting Methyl 2-Bromomethylbenzoate with other molecular entities, scientists can construct novel compounds designed to protect neurons from damage, a critical step in drug discovery for conditions like stroke, Alzheimer's, and Parkinson's disease.

The synthesis of Methyl 2-Bromomethylbenzoate itself is often achieved through methods such as the bromination of methyl o-toluate using N-bromosuccinimide (NBS) in the presence of a radical initiator like benzoyl peroxide (BPO). Understanding the synthesis pathways can be beneficial for procurement professionals when assessing the production capabilities of potential manufacturers. When you are ready to buy or purchase this compound, seeking out a reliable supplier that can provide consistent purity and detailed technical documentation is paramount.

For R&D departments, having access to well-characterized intermediates like Methyl 2-Bromomethylbenzoate is essential for accelerating project timelines and achieving successful outcomes. When considering where to obtain this chemical, looking for established manufacturers in regions known for chemical production, such as China, often provides access to competitive prices and a robust supply chain. Ensuring quality and availability will pave the way for groundbreaking research and development.